MD Anderson Cancer and Research Center

Houston, Texas 77030

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin

Studies at this site

• An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study — Stopped early